ANALYTICAL PURITY >99.8%
LOT: X7A-99
RETATRUTIDE
10MG
HPLC VALIDATED LYOPHILIZED POWDER
CLINICAL GIP/GLP-1/GCG AGONIST

Advanced Metabolic Synthesis

Select your designated research compound and operational parameters to initiate secure logistics dispatch.

1. Compound Designation
Retatrutide
Tri-Agonist Architecture
Tirzepatide
Dual-Agonist Architecture
2. Vial Concentration
3. Acquisition Parameters
1
₦0
4. Target Coordinates
Requires ₦0 logistics fee.